VivaCell presents VCE-003.2 and VCE-004.8 in the I Meeting of Traslational Research on Rare Diseases at IMIBIC

01/12/2015

Imagen Noticia

Córdoba, December 1st 2015. Researches, health professionals and patients attend the I Meeting of Traslational Research on Rare Diseases at IMIBIC. During the meeting, VivaCell has shown the research programs for VCE-003.2 in Huntington’s Disease and VCE-004.8 in Scleroderma. VivaCell, as sponsor of the Meeting, has highlighted the importance and success of the international politics that have enhanced the private research and commercialization of treatment for rare diseases under the Orphan Drug Designation.

Developed with DoPlanning